Airsculpt Technologies, INC. 8-K Filing
Ticker: AIRS · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1870940
Sentiment: neutral
Filing Stats: 737 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2025-11-17 18:10:40
Key Financial Figures
- $0.001 — e on Which Registered: Common Stock, $0.001 par value per share AIRS The Nasdaq
Filing Documents
- tm2531412d1_8k.htm (8-K) — 28KB
- tm2531412d1_ex99-1.htm (EX-99.1) — 6KB
- tm2531412d1_ex99-1img001.jpg (GRAPHIC) — 5KB
- 0001104659-25-113294.txt ( ) — 209KB
- airs-20251114.xsd (EX-101.SCH) — 3KB
- airs-20251114_lab.xml (EX-101.LAB) — 33KB
- airs-20251114_pre.xml (EX-101.PRE) — 22KB
- tm2531412d1_8k_htm.xml (XML) — 4KB
02. Departure of Directors or Certain Officers; Election
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 14, 2025, the board of directors (the "Board") of AirSculpt Technologies, Inc. (the "Company") elected Michael Doyle to serve as a Class III director of the Board and as the Non-Executive Chairman of the Board, in each case effective as of the same date. Mr. Doyle will stand for election by stockholders at the Company's 2027 annual meeting of stockholders. Mr. Doyle has served as Managing Partner of Vesey Street Capital Partners since January 2025. Mr. Doyle founded MD Healthcare Partners in 2018 and served as its Chief Executive Officer until December 2024. Previously, Mr. Doyle held several leadership positions, including Chief Executive Officer from 2009 to September 2017, at Surgery Partners (NASDAQ: SGRY), where he led the organization for approximately 15 years and helped to scale it from 3 to over 175 locations. Mr. Doyle has served as Chairman of Orthopedic Solutions Management, a leading orthopedic physician organization, since September 2021, and as Chairman of North America Dental Group since June 2020. He has also served from August 2019 to August 2025 as Chairman of GastroMD, a leading gastroenterologist organization, and from October 2018 to September 2021 as a member of the board of managers of Elite Body Sculpture, the predecessor of the Company prior to its initial public offering. Mr. Doyle will not be compensated for his service as a director and as the Non-Executive Chairman of the Board. There are no arrangements or understandings between Mr. Doyle and any other person pursuant to which he was elected as a director of the Company. There are no family relationships between Mr. Doyle and any other director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated November 17, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 17, 2025 AirSculpt Technologies, Inc. By: /s/ Dennis Dean Name: Dennis Dean Title: Chief Financial Officer [ Signature Page to the Form 8-K ]